Cargando…
The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
BACKGROUND: Sarcopenia was a frequent chronic complication in patients with type 2 diabetes mellitus (T2DM), and previous evidence showed conflicting results regarding the prevalence and risk factors of sarcopenia in T2DM. In the current study, we aimed at systematically exploring the prevalence and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414692/ https://www.ncbi.nlm.nih.gov/pubmed/34479652 http://dx.doi.org/10.1186/s13098-021-00707-7 |
_version_ | 1783747830716825600 |
---|---|
author | Ai, Yaqin Xu, Ruoxin Liu, Lingping |
author_facet | Ai, Yaqin Xu, Ruoxin Liu, Lingping |
author_sort | Ai, Yaqin |
collection | PubMed |
description | BACKGROUND: Sarcopenia was a frequent chronic complication in patients with type 2 diabetes mellitus (T2DM), and previous evidence showed conflicting results regarding the prevalence and risk factors of sarcopenia in T2DM. In the current study, we aimed at systematically exploring the prevalence and risk factors of sarcopenia in patients with T2DM. METHODS: PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched to identify observational studies which investigated the prevalence and risk factors of sarcopenia in patients with T2DM. The quality of individual included studies was evaluated using The Newcastle–Ottawa scale. Pooled effects regarding prevalence and associated factors were calculated using random-effects models. The potential publication bias was assessed via funnel plot and Egger test. RESULTS: Twenty-eight studies involving 16,800 patients were included in our meta-analysis. The pooled prevalence of sarcopenia in patients with T2DM was 18% (95% CI 0.15–0.22; I(2) = 97.4%). The pooled results showed that elder age (OR 4.73; 95% CI 4.30–5.19; I(2) = 85.6%), male gender, chronic hyperglycemia (higher HbA1c) (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) and osteoporosis (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) was predictors for sarcopenia, whereas patients with lower BMI (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) and metformin administrations (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) were not prone to get sarcopenia. The funnel plot and statistical tests showed no obvious publication bias. CONCLUSIONS: Sarcopenia was frequent in T2DM patients. Elder age, male gender and chronic hyperglycemia, Osteoporosis were significant risk factors for Sarcopenia. Lower BMI and metformin administrations were associated with lower risk of sarcopenia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-021-00707-7. |
format | Online Article Text |
id | pubmed-8414692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84146922021-09-09 The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Ai, Yaqin Xu, Ruoxin Liu, Lingping Diabetol Metab Syndr Research BACKGROUND: Sarcopenia was a frequent chronic complication in patients with type 2 diabetes mellitus (T2DM), and previous evidence showed conflicting results regarding the prevalence and risk factors of sarcopenia in T2DM. In the current study, we aimed at systematically exploring the prevalence and risk factors of sarcopenia in patients with T2DM. METHODS: PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched to identify observational studies which investigated the prevalence and risk factors of sarcopenia in patients with T2DM. The quality of individual included studies was evaluated using The Newcastle–Ottawa scale. Pooled effects regarding prevalence and associated factors were calculated using random-effects models. The potential publication bias was assessed via funnel plot and Egger test. RESULTS: Twenty-eight studies involving 16,800 patients were included in our meta-analysis. The pooled prevalence of sarcopenia in patients with T2DM was 18% (95% CI 0.15–0.22; I(2) = 97.4%). The pooled results showed that elder age (OR 4.73; 95% CI 4.30–5.19; I(2) = 85.6%), male gender, chronic hyperglycemia (higher HbA1c) (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) and osteoporosis (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) was predictors for sarcopenia, whereas patients with lower BMI (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) and metformin administrations (OR 1.16; 95% CI 1.05–2.47; I(2) = 99.2%) were not prone to get sarcopenia. The funnel plot and statistical tests showed no obvious publication bias. CONCLUSIONS: Sarcopenia was frequent in T2DM patients. Elder age, male gender and chronic hyperglycemia, Osteoporosis were significant risk factors for Sarcopenia. Lower BMI and metformin administrations were associated with lower risk of sarcopenia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-021-00707-7. BioMed Central 2021-09-03 /pmc/articles/PMC8414692/ /pubmed/34479652 http://dx.doi.org/10.1186/s13098-021-00707-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ai, Yaqin Xu, Ruoxin Liu, Lingping The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
title | The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
title_full | The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
title_fullStr | The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
title_full_unstemmed | The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
title_short | The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
title_sort | prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414692/ https://www.ncbi.nlm.nih.gov/pubmed/34479652 http://dx.doi.org/10.1186/s13098-021-00707-7 |
work_keys_str_mv | AT aiyaqin theprevalenceandriskfactorsofsarcopeniainpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysis AT xuruoxin theprevalenceandriskfactorsofsarcopeniainpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysis AT liulingping theprevalenceandriskfactorsofsarcopeniainpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysis AT aiyaqin prevalenceandriskfactorsofsarcopeniainpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysis AT xuruoxin prevalenceandriskfactorsofsarcopeniainpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysis AT liulingping prevalenceandriskfactorsofsarcopeniainpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysis |